Lung Fibrosis Sequelae After Recovery from COVID-19 Infection
- PMID: 33839710
- DOI: 10.3855/jidc.13686
Lung Fibrosis Sequelae After Recovery from COVID-19 Infection
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that causes coronavirus diseases 2019 (COVID-19). The SARS-CoV-2 is very contagious and nobody is known to be immune to it. The post-infected lung would leave a scar known as fibrosis, a scar tissue. A study from Wuhan, China suggested the development of fibrosis, though it was too early to label these lung changes as irreversible fibrosis in a time range of 3 weeks. The occurrence of fibrosis indicates a chronic infection which greatly contributes to the hallmark symptom of COVID-19 induced ARDS such as shortness of breath and chest pain. However, many of those studies have not yet explained the condition of the patient's lung after total recovery from the COVID-19. This report demonstrates the clinical symptoms, chest CT scan, spirometry, and blood gas analysis of patient after total recovery from the COVID-19 with appearance lung fibrosis.
Keywords: COVID-19; lung fibrosis; recovery.
Copyright (c) 2021 Agus Dwi Susanto, Paulus Arka Triyoga , Fathiyah Isbaniah, Aulya Fairuz, Hans Cendikiawan , Ferdynand Zaron, Intan Aryanti, Sarah Naura Irbah, Moulid Hidayat.
Conflict of interest statement
No Conflict of Interest is declared
Similar articles
-
Three Cases of COVID-19 Pneumonia in Female Patients in Italy Who Had Pulmonary Fibrosis on Follow-Up Lung Computed Tomography Imaging.Am J Case Rep. 2020 Nov 21;21:e926921. doi: 10.12659/AJCR.926921. Am J Case Rep. 2020. PMID: 33219200 Free PMC article.
-
Occurrence of pulmonary residuals as one of the sequelae of COVID-19 and it's predictors among moderate and severe cases.Indian J Tuberc. 2021 Oct;68(4):450-456. doi: 10.1016/j.ijtb.2021.01.006. Epub 2021 Feb 3. Indian J Tuberc. 2021. PMID: 34752312 Free PMC article.
-
Pulmonary fibrosis and its related factors in discharged patients with new corona virus pneumonia: a cohort study.Respir Res. 2021 Jul 9;22(1):203. doi: 10.1186/s12931-021-01798-6. Respir Res. 2021. PMID: 34243776 Free PMC article.
-
The Management of Pulmonary Fibrosis in COVID-19.Acta Med Indones. 2021 Apr;53(2):233-241. Acta Med Indones. 2021. PMID: 34251354 Review.
-
Post-COVID pulmonary fibrosis: therapeutic efficacy using with mesenchymal stem cells - How the lung heals.Eur Rev Med Pharmacol Sci. 2021 Mar;25(6):2748-2751. doi: 10.26355/eurrev_202103_25438. Eur Rev Med Pharmacol Sci. 2021. PMID: 33829461 Review.
Cited by
-
Exploratory analysis of serum Krebs von den Lungen-6, blood gas analysis & Brixia score in determining COVID-19 severity & mortality.Indian J Med Res. 2024 May;159(5):468-478. doi: 10.25259/ijmr_2516_22. Indian J Med Res. 2024. PMID: 39382415 Free PMC article.
-
Long-Term Clinical and Immunological Impact of Severe COVID-19 on a Living Kidney Transplant Recipient - A Case Report.Front Immunol. 2021 Sep 8;12:741765. doi: 10.3389/fimmu.2021.741765. eCollection 2021. Front Immunol. 2021. PMID: 34567007 Free PMC article.
-
A Systematic Review of Chest Imaging Findings in Long COVID Patients.J Pers Med. 2023 Feb 1;13(2):282. doi: 10.3390/jpm13020282. J Pers Med. 2023. PMID: 36836515 Free PMC article. Review.
-
Post-Acute COVID-19 Syndrome for Anesthesiologists: A Narrative Review and a Pragmatic Approach to Clinical Care.J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt A):2727-2737. doi: 10.1053/j.jvca.2021.09.051. Epub 2021 Oct 3. J Cardiothorac Vasc Anesth. 2022. PMID: 34688543 Free PMC article. Review.
-
Factors Associated With Persistence of Dyspnea and Change in Health-Related Quality of Life in Patients With COVID-19 After Discharge.Cureus. 2022 Nov 2;14(11):e31009. doi: 10.7759/cureus.31009. eCollection 2022 Nov. Cureus. 2022. PMID: 36475221 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous